40
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Endothelin-1 activity in pregnancy

, &
Pages 590-593 | Published online: 02 Jul 2009

  • Arai H., Hori S., Aramori I., Ohkubo H. and Nakanishi S. (1990) Cloning and expression of a cDNA encoding an endothelin receptor. Nature, 348, 730-732.
  • Benigni A. Orisio S., Gaspari F., Frusca T., Amuso G. and Remuzzi G. (1992) Evidence against a pathogenic role for endothelin in pre-eclampsia. British Journal of Obstetrics and Gynaecology, 99, 798-802.
  • Brown C. D., Barnes K. and Turner A. J. (2000) Functional significance of the isoforms of endothelin-converting enzyme-1. Journal of Cardiovascular Pharmacology, 36(Supp.1), S26-S27.
  • Bussen S., Sutterlin M. and Steck T. (1999) Plasma endothelin and big endothelin levels in women with severe pre-eclampsior HELLP syndrome. Archives of Gynecology and Obstetrics, 262, 113-119.
  • Clark B. A., Halvorson L. Sachs B. and Epstein F. H. (1992) Plasma endothelin levels in pre-eclampsia: elevation and correlation with uric acid and renal impairment. American Journal of Obstetrics and Gynecology, 166, 962-968.
  • deNucci G., Thomas R., D'Orleans-Juste P., Antunes E., Walder C., Warner T. D. and Vane J. R. (1988) Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelin derived relaxing factor. Proceedings of the National Academy of Sciences of the United States of America, 85, 9797-9800.
  • Di Iorio R., Marinoni E., Anceschi M., Emiliani S., Letizia C. and Cosmi F. V (1996) Amniotic fluid endothelin-1 levels are increased in pregnancy induced hypertension and intrautcrine growth retardation. American Journal of Reproductive Immunology, 36, 260-263.
  • Gibbons G. H. (1997) Endothelial function as a determinant of vascular function and structure: a new therapeutic target. American Journal of Cardiology, 79, 3-8.
  • Granger J. P., Alexander B. T., Bennett W. A. and Khalil R. A. (2001a) Pathophysiology of pregnancy-induced hypertension. American Journal of Hypertension, 14, 178S-185S.
  • Granger J. R, Alexander B. T., Llinas M. T., Bennett W. A. and Khalil R. A. (2001b) Pathophysiology of hypertension during pre-eclampsia linking placental ischaemia with endothelial dysfunction. Hypertension, 38, 718-722.
  • Harvey-Wilkes K. B., Nielsen H. C. and D'Alton M. E. (1996). Elevated endothelin levels are associated with increased placental resistance. American Journal of Obstetrics and Gynecology, 174, 1599-1604.
  • Inoue A., Yanagisawa M., Takuwa Y., Mitsui Y., Kohayashi M. and Masaki T. (1989) The human preproendothelin-1 gene. Complete nucleotidc sequence and regulation of expression. Journal of Biological Chemistry, 264, 14954-14959.
  • Iwata I., Takagi T., Yamaji K. and Tanizawa O. (1991) Increase in the concentration of immunoreactive endothelin in human pregnancy. Journal of Endocrinology, 129, 301-307.
  • Kaur S., Frishman W.H., Singh I., Tamirisa P. and Kumar A (2001) Endothelin as a therapeutic target in the treatment of cardiovascular disease. Heart Disease, 3, 176-188.
  • Lumme R., Laatikainen T., Vuoltecnaho O. and Leppauloto J. (1992), Plasma endothelin, atrial natriuretic peptide (ANP) and uterine and umbilical artery flow velocity waveforms in hypertensive pregnancies. British Journal of Obstetrics and Gynaecology, 99, 761-764.
  • Mastrogiannis D. S., O'Brien W. F. Krammer J. and Benoit R. (1991) Potential role of endothelin-1 in normal and hypertensive pregnancies. American Journal of Obstetrics and Gynecology, 165, 1711-1716.
  • McQueen J., Kingdom J. C. P., Connell J. M. C. and Whittle M. J. (1993). Fetal endothelin levels and placental vascular endothelin receptors in intrauterine growth retardation. Obstetrics and Gynaecology, 82, 992-998.
  • Naiker S., Naidoo S., Naicker T., Gathiram P., Nadar A. and Moodley J. (2001) Immunolocalisation and endothelin-1 values in pre-eclampsia: an immunocytochemical study. Journal of Obstetrics and Gynaecology, 21, 39-45.
  • Nieaud V, Poirier O., Behauge I., Herrmann S. M., Mallet C., Troesch A., Bouyer J., Evans A., Luc G., Ruidavets J. B., Arveiler D., Bingham A., Tiret L., and Cambien F. (1999) Polymorphisms of the endothelin-A and -B receptor genes in relation to blood pressure and myocardial infarction. American Journal of Hypertension, 12, 304-310.
  • Plumpton C., Ferro C. J., Haynes W. G., Webb D. J. and Davenport A. P. (1996) The increase in human plasma immunoreactive endothelin but not big endothelin-1 or its C terminal fragment induced by systemic administration of the endothelin antagonist TAK 044. British Journal of Pharmacology, 119, 311-314.
  • Robaut C., Mondon F., Bandet J., Ferre F. and Cavero I. (1991) Regional distribution and pharmacological characterization of (125I) endothelin-1 binding sites in human fetal placental vessels. Placenta, 12, 55-67.
  • Saida K., Kometani N., Masuda H., Oka S. and Uehide T. (2000) Structure of mouse preproendothelin-3 and phylogenetic analysis of the endothelins. Journal of Cardiovascular Pharmacology, 36 (Supp 1), S1-S4.
  • Saijo Y., Maeda K., Nakaya Y. Kamada M., Mitani R., Endo S., Irahara M., Yamano S. and Aono T. (2001) Altered sensitivity to a novel vasoconstrictor endothelin-1 (1-31) in myometrium and umbilical artery of women with severe pre-eclampsia. Biochemical and Biophysical Research Communications, 286, 964-967.
  • Seo B., Oemar R., Siebenmann R., von Segesser L. and Luscher T. F. (1994) Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation, 89, 1203-1208.
  • Shimada K., Matsushita Y., Wakabayashi K., Takahashi M., Matsubara A., Ijima Y. and Tanzawa K. (1995) Cloning and functional expression of human endothelin converting enzyme cDNA. Biochemical Biophysical Research Communications, 207, 807-812.
  • Singh H. J., Rahman A., Larmie K. T. and Nila A. (2001) Endothelin-1 in feto-placental tissue from normotensivepregnant women and women with pre-eclampsia. Acta Obstetricia Gynecologica Scandinavica, 80, 99-103.
  • Vane J. R. (2001) My life and times with enzymes and mediators. Medical Science Monitor, 7, 790-800.
  • Vane J. R. and Botting R. M. (1992) Secretory functions of the vascular endothelium. Journal of Physiology and Pharmacology, 43, 195-207.
  • Vlachojannis J., Tsakas S., Petropoulou C. and Kurz, P. (1997) Increased renal excretion of edothelin-1 in nephrotic patients. Nephrology, Dialysis, Transplantation, 12, 470-473.
  • Webb D. J., Monge J. C., Rabelink T. J. and Yanagisawa M. (1998) Endothelin: new discoveries and rapid progress in the clinic. Trends in Pharmacological Sciences, 19, 5-8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.